Metabolic Complications Precede Alloreactivity and are Characterized by Changes in ST2 Signaling

被引：0
|
作者：
Johnpulle, Romany Anne Nilanthi [1 ]
Paczesny, Sophie [2 ]
Jung, Dae Kwang [3 ]
Daguindau, Etienne [4 ]
Jagasia, Madan H. [3 ]
Savani, Bipin N. [5 ]
Chinratanalab, Wichai [3 ]
Cornell, Robert F. [5 ]
Goodman, Stacey [3 ]
Greer, John [3 ]
Kassim, Adetola A. [3 ]
Sengsayadeth, Salyka [3 ]
Engelhardt, Brian G. [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Med, Nashville, TN USA
[2] Indiana Univ, Sch Med, Indianapolis, IN USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
69
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [41] Metformin prevents adverse cardiac remodeling by modulation of IL-33/ST2 signaling
    Asensio-Lopez, M. C.
    Sanchez-Mas, J.
    Manuel Lax, A. M. Antonio
    Fernandez Del Palacio, M. J.
    Caballero, L.
    Santarelli, G.
    Pascual-Figal, D. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 369 - 369
  • [42] A Novel Interleukin 33/ST2 Signaling Regulates Inflammatory Response in Human Corneal Epithelium
    Lin, Jing
    Zhang, Lili
    Zhao, Guiqiu
    Su, Zhitao
    Deng, Ruzhi
    Pflugfelder, Stephen C.
    Li, De-Quan
    PLOS ONE, 2013, 8 (04):
  • [43] ST2 Negatively Regulates TLR2 Signaling, but Is Not Required for Bacterial Lipoprotein-Induced Tolerance
    Liu, Jinghua
    Buckley, Julliette M.
    Redmond, H. Paul
    Wang, Jiang Huai
    JOURNAL OF IMMUNOLOGY, 2010, 184 (10): : 5802 - 5808
  • [44] IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
    Sanada, Shoji
    Hakuno, Daihiko
    Higgins, Luke J.
    Schreiter, Eric R.
    McKenzie, Andrew N. J.
    Lee, Richard T.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (06): : 1538 - 1549
  • [45] Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases
    Thanikachalam, Punniyakoti Veeraveedu
    Ramamurthy, Srinivasan
    Mallapu, Poojitha
    Varma, Sudhir Rama
    Narayanan, Jayaraj
    Abourehab, Mohammed A. S.
    Kesharwani, Prashant
    CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 71-72 : 94 - 104
  • [46] IL-33/ST2 Alarmin Signaling Axis in Myeloid Cells Regulates Kidney Injury
    Sabapathy, Vikram
    Costlow, Gabrielle
    Cheru, Nardos T.
    Price, Airi
    Venkatadri, Rajkumar
    Dogan, Murat
    Mohammad, Saleh
    Sharma, Rahul
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 163 - 163
  • [47] IL-33/ST2 signaling in pain and itch: Cellular and molecular mechanisms and therapeutic potentials
    Li, Peiyi
    Yu, Qing
    Nie, Huimin
    Yin, Chengyu
    Liu, Boyi
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [48] The intriguing role of IL33/ST2 axis signaling in oral diseases - A systematic review
    Kamboj, Mala
    Keerthika, R.
    Narwal, Anjali
    Gupta, Ambika
    Devi, Anju
    Kumar, Adarsh
    Sharma, Gitika
    ADVANCES IN MEDICAL SCIENCES, 2024, 69 (02): : 264 - 271
  • [49] Nociceptor Interleukin 33 Receptor/ST2 Signaling in Vibration-Induced Muscle Pain in the Rat
    Alvarez, Pedro
    Bogen, Oliver
    Levine, Jon D.
    JOURNAL OF PAIN, 2020, 21 (3-4): : 506 - 512
  • [50] Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin
    Zdravkovic, Nemanja
    Shahin, Allen
    Arsenijevic, Nebojsa
    Lukic, Miodrag L.
    Mensah-Brown, Eric P. K.
    MOLECULAR IMMUNOLOGY, 2009, 47 (01) : 28 - 36
12345